ANXA2 is a multifunctional protein and known to act as a co‐receptor for tissue plasminogen activator (tPA) on the surface of endothelial and cancer cells, thereby affecting fibrinolytic activity and neoangiogenesis as well as invasive and metastatic properties. The gene discussed is PLAT; the disease is cancer.